Resultados de la búsqueda 81-90 of 7529 for ai作文生成器官网,写论文ai网站,ai绘画大师网页版,ai生成图片的网站,超火ai官网,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  3. Médicos - Medicina de laboratorio y patología - Mayo Clinic

    Shweta Agarwal, M.D.. Jacksonville, FL. Hussam Al Kateb, Ph.D. Rochester, MN.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, ...

  6. Enfermedades infecciosas - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to determine if patients treated with fluoroquinolone (FQ) antibiotics have depletion of mitochondrial DNA (mtDNA) in buccal ...

  7. Neurological examinations - Mayo Clinic

    Your nervous system includes your brain, spinal cord, nerves and muscles. A neuro exam can help your healthcare team find nervous system conditions and figure ...

  8. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia Syndrome ( ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...